New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
08:38 EDTCNCCentene reimbursement benefits weighted to 2H14, says Susquehanna
Susquehanna remains Positive on Centene following better than expected Q4 results citing the long term revenue growth opportunities presented by the new healthcare law coverage expansions. The firm noted the reimbursement benefits are weighted to the second half of 2014 and as such Q1 earnings could differ materially from their estimates. Price target is $68.
News For CNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CNC

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use